Materials and Methods
Mice. BALB/c mice were obtained from Health Research, Inc., West Seneca, New York. DBA/ 1 and C57BL/6 mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. Mice used in these experiments were 10-16 wk of age and were maintained on laboratory chow and acidifiedchlorinated water a d lib.
Antigens. The random synthetic terpolymer of I~glutamic acide°-L-alanine3°-L-tyrosine 1° (GAT), average tool wt 30,800 daltens and the copolymer of L-glutamic acidS°-L-tyrosine 5° (GT), average mol wt 32,000, were purchased from Miles Laboratories, Inc., Miles Research Division, Elkhardt, Ind. Stock solutions (10 ~g/ml) were prepared in normal saline containing 1% Na2CO3 at pH 9.0-9.5. MBSA was purchased from Worthington Biochemical Corp., Freehold, N.J.
Immunizations. Primary antibody responses were elicited by injecting mice intraperitoneally with 10, 50, or 100 ~g GAT, 10 ~g GAT as GAT-MBSA, or 10 ~g GT as GT-MBSA in a mixture containing 2 x 10 ~ killed Bordetella pertussis organisms and 10 /~g of an aluminum-magnesium hydroxide gel (Maalox, W. H. Rorer, Inc., Fort Washington, Pa.). 7 days afar injection, spleens were assayed for GAT-or GT-specific plaque-forming cells (PFC) (2) . To investigate secondary antibody responses, mice were initially immunized intraperitoneally with 50/~g GAT, 50/~g GAT as GAT-MBSA or 50 ~g GT as GT-MBSA in a mixture containing pertussis and/or Maalox or Maalox alone as indicated in the tables. A second injection of 10 ~g of antigen followed 3 or 21 days later. Spleens from injected animals were assayed for GAT-or GT-specific PFC 4-11 days after second injection.
To investigate suppression of the secondary antibody response of nonresponder mice, the animals were first injected with 100 ~g GT in Maalox (BALB/c) or 10 ~g GAT in Maalox (DBA/1). 3 and 6 days later, mice were injected with GT-MBSA (BALB/c) and GAT-MBSA (DBA/1) according to the repeated immunization protocol described above.
Antigen-Binding Assay. The primary and secondary GAT-specific circulating antibody responses of BALB/c mice were measured. Serum samples were diluted 1/5 in phosphate-buffered saline (PBS) and then assayed by a modified Farr assay described previously (13) .
Sephadex G-200 Gel Filtration. The separation of IgM and IgG anti-GAT antibodies was
performed by gel filtration on a 1.5 x 90 cm Sephadex G-200 (Pharmacia Fine Chemicals, Piscataway, N. J.) column. The gel was equilibrated at 4°C in PBS, and the flow rate was maintained at 5 ml/h with a peristaltic pump. The column was calibrated using Blue dextran 2,000 (2 x 10 e tool wt, Pharmacia Fine Chemicals), bovine gamma globulin (BGG, 150,000 tool wt), bovine serum albumin (BSA, 66,000 mol wt), and cytochrome c (12,500 mol wt) as markers.
The optical density of the eluate was recorded with an LKB UV recorder. BALB/c mice were immunized twice with GAT in Maalox pertussis as described above; 7 days after the second injection (day 10) the mice were bled. 0.5 ml of heat-inactivated (56°C 30 rain) serum was loaded on the column. The optical density of the eluted material was recorded and the hemagglutinin titer of the various fractions measured using GAT-SRBC as indicator cells.
Hemolytic Plaque Assay. The antibody responses to GAT, GAT-MBSA, or GT-MBSA were assayed by a modification of the Jerne hemolytic plaque technique described previously (2) . GAT was coupled to SRBC as described previously (2) . As in previous studies, GAT-SRBC were used to detect GAT or GT-specific PFC because of the extensive cross-reactivity of the antibody produced. IgM PFC were enumerated after incubation of GAT-SRBC and spleen cells using guinea pig serum as a source of C +. A goat anti-mouse p-chain antiserum prepared against MOPC-104E and absorbed with k-light chains (a gift from Dr. R. Asofsky) was used to inhibit IgM PFC (14) . IgG PFC were developed with polyvalent rabbit anti-mouse IgG serum and C' in the presence of goat anti-~-chain antibody (2, 14) . Both IgM and IgG antigen-specific plaques were determined by subtracting the number of PFC obtained in the presence of a suitable dilution of GAT (25 ~g/ml) from the number of plaques detected on GAT-SRBC in the absence of the specific inhibitor (4).
Results

Effect of Repeated Immunization on the PFC Responses of BALB/c Mice to
GAT. Previous studies have shown that genetic responder and nonresponder mice fail to develop a primary IgM GAT-specific PFC response in vivo or in vitro (2) . Primary in vivo PFC responses to the copolymers GA and GT, likewise, have Mice received a single injection of 10 ~g GAT in Maalox-pertussis. § IgM response not significantly different (P = 0.461) from no antigen control. II Mice received a single injection of 100 ~g GAT in Maalox-pertussis. been found to be restricted to the IgG class (4). In addition, a primary IgM response to GT could not be detected in mice pretreated with cyclophosphamide in order to remove suppressor T cells (Waltenbaugh, unpublished observations) . In experiments relating the structure of GAT with its antigenic properties, we have observed a marked enhancement in the number of GAT-specific PFC's in mice that had received two injections of GAT in Maalox pertussis (15) . Mice receiving two injections of GAT, at a 3-day interval, display a two to threefold increase in the number of IgG PFC's (Table I , Experiment I). Moreover, after two injections of GAT, GAT-specific PFC's of the IgM class are elicited. The occurrence of IgM PFC's is due to repeated immunization with the antigen; Maalox pertussis followed by GAT in Maalox pertussis does not cause the formation of significant numbers of GAT-specific IgM plaques. The highest numbers of both IgM and IgG GAT-specific PFC's were seen after repeated injections of GAT in Maalox pertussis. The time period between the first and second injection of GAT in Maalox pertussis may be extended up to 3 wk (Table  I , Experiment II), without any effect upon either the IgM or IgG PFC responses.
Effect of Repeated Immunization of Serum Antibody.
We have analyzed the sera of animals receiving secondary immunization with GAT both by a modified Farr assay and passive hemagglutination. The data presented in Table II show that significant antigen binding, using the condition of our assay, is detected in the sera only after the secondary immunization with GAT. In contrast, the sera obtained after a single GAT injection do not show significant binding. In the hemagglutination assay, using GAT-SRBC as indicator cells, mice receiving two injections of GAT gave a titer of 1/1,024, whereas a titer of 1/32 was seen after single immunization. Pretreatment of these sera with 2-mercaptoethanol (16) completely abolishes the hemagglutination titer precluding the distinction between IgM and IgG antibodies by this method in early sera (17) .
Separation of IgM and IgG Antibodies in the Sera of BALB/c Mice Receiving Repeated GAT Immunization. We have used a Sephadex G-200 column to
physically identify IgM anti-GAT antibodies in the sera of BALB/c mice that have received double GAT immunizations. Fig. 1 shows two peaks of hemagglutinating activity eluted from the column. The larger peak elutes in the void volume (marker, blue dextran) corresponding to the (19S) IgM class of antibodies. The smaller peak elutes at the same volume as BGG and thus corresponds to IgG anti-GAT antibodies. Since IgM antibodies are known to hemagglutinate more efficiently than IgG, the size of the hemagglutination peaks do not necessarily reflect the respective amount of antibodies.
Duration of the IgM PFC Responses of BALB/c Mice to GAT. Spleens of
BALB/c mice immunized twice with GAT in Maalox pertussis show an IgM as well as an IgG PFC response 7 days after immunization. The data in Table III show that IgM and IgG GAT-specific PFC are seen at 4 and 11 days as well as 7 days after the second immunization. The appearance of GAT-specific IgM PFC is, therefore not a transient phenomenon.
Effect of Repeated Immunization in Responder and Nonresponder
Mice. The data in Table IV show that another GAT-responder strain, C57BL/ 6, is capable of producing GAT-specific IgM PFC after immunization twice with GAT in Maalox-pertussis as described above. Although not shown, the primary response of a limited number of C57BL/6 mice was restricted to the IgG class, confirming previously reported results (2) . Repeated immunization of a GAT nonresponder strain, DBA/1, with GAT in Maalox pertussis, however, fails to stimulate either IgM or IgG PFC responses.
A characteristic property of GT-or GAT-nonresponder animals is their ability to develop a GAT or GT-specific responses when injected with GAT or GT complexed to an immunogenic carrier such as MBSA. Primary responses to GT-MBSA and GAT-MBSA were found to be also restricted to IgG class of antibody (2, 5) . However, nonresponder mice, BALB/c or DBA/1, injected twice with GT-MBSA or GAT-MBSA, respectively, can mount an IgM as well as an IgG antigen-specific PFC response (Table V) . 
Antigenic Suppression of the IgM and IgG PFC Responses of GAT and GT Nonresponder Mice.
Earlier studies from our laboratory have shown that injection of GT or GAT into nonresponder mice bearing the H-2 d or H-2 q haplotype stimulate suppressor T cells capable of inhibiting antigen-specific IgG PFC responses to GT-MBSA or GAT-MBSA, respectively (5, 12) . The effect of GT preimmunization on the IgM and IgG PFC responses of BALB/c mice is shown in Table VI . Both IgM and IgG responses are suppressed. Likewise, GAT preimmunization diminishes considerably the GAT-MBSA IgM and IgG PFC responses of DBA/1 mice. It is well documented that the inhibition of IgG PFC responses in the GAT and GT systems is due to active suppression mediated by T cells (18) .
The data presented in Table VII illustrate that the transfer of 20 × l0 s cells from GT-primed BALB/c mice results in the suppression of both the IgM and IgG PFC responses of BALB/c mice demonstrating, therefore, the presence of suppressor cells "active" on both IgM and IgG responses in GT-primed mice.
Discussion
Previous studies from our laboratory have shown that both responder and nonresponder mice develop only IgG primary responses to GAT, GT, and GA (2) (3) (4) (5) . In the present study, we report the appearance of IgM antibodies in secondary responses to GAT in responder and to GAT-MBSA or GT-MBSA in nonresponder mice. We have verified the presence of antigen-specific IgM antibodies GAT/MP GAT/MP 4 <200 <200 * Mice received 50 ~g GAT in Maalox pertussis intraperitoneally followed 3 days later by 10 ~g GAT in Maalox pertussis, intraperitoneally. 7 days later, the number of GAT-specific PFC per spleen was determined. It was shown earlier that a primary immunization of C57BL/6 with GAT does not elicit an IgM response. Although not shown, these results were confirmed using a limited number of animals.
both functionally by the formation of direct PFC which are totally inhibitable by a well-characterized goat anti-mouse re-chain antiserum (14) and physically by gel filtration on a Sephadex G-200 column. Simultaneous with the appearance of the IgM antibodies in the secondary response, we have observed a marked enhancement in the IgG antibody response, confirmed by both the plaque assay and by an antigen-binding assay. The appearance of GAT-or GT-specific antibodies of the IgM class is dependent upon the repeated administration of antigen. The quantity of antigen does not appear to be the critical parameter in these experiments; BALB/c mice injected once with 10 ftg GAT (Table I) * Mice were immunized intraperiteneally with either 50 p~g of GT as GT-MBSA or 50 ~g GAT as GAT-MBSA in Maalox pertuesis initially followed 3 days later by an i.p. injection of 10 p,g OT as GT-MBSA or 10/~g OAT as GAT-MBSA in Maalox pertussis. On day 10, spleens from these mice were assayed for antigen-specific PFC. ~: Nine mice were used per date group.
Furthermore, the induction of IgM antibodies is not limited to responder animals; nonresponder animals produce antigen-specific IgM when either GT or GAT complexed to MBSA are administered twice.
The restriction of primary responses to GAT, GA, GAT-MBSA, and GT-MBSA to the IgG class together with the requirement of repeated immunization to stimulate IgM antibody responses to these antigens raise important issues concerning the regulation of class-specific antibody responses and challenge the generally accepted belief that IgM antibody responses (when they occur) are the earliest antibody responses and always precede IgG antibody responses, particularly after primary immunization. These conclusions were based upon the responses to particulate antigens such as SRBC and bacteria and also upon the result of immunization with antigens that have a thymus-independent as well as a thymus-dependent component, such as (T,G)-A--L or polymerized flagellin. The strong possibility must be entertained that the commitment to early IgM responses is a property of thymus-independent antigens, whereas thymusdependent antigens which require the activity of helper T cells and often elicit the regulatory activity of specific suppressor T cells may sometimes stimulate primary IgG and secondary IgM responses as seen in the current experiments. The appearance of IgM in the secondary antibody response in our experiments may be explained by the existence of two helper T-cell populations, one specific for IgM responses and the other for IgG. Differential activation of these two populations could explain why IgG helper cells might be triggered after only a single injection of antigen, while IgM helpers would require a second injection of antigen for stimulation. An alternative hypothesis would be that injection of antigen into responder animals leads to the stimulation of both antigen-specific helper and suppressor T cells. The suppressor cells stimulated after a single injection of antigen may preferentially affect the IgM response, therefore, the effect of the helpers would lead to the production of only IgG antibodies. According to this hypothesis, a second injection of antigen would shift the helper-suppressor balance in favor of the helper cells explaining the appearance of IgM and the enhancement of IgG antibody levels. Both hypotheses also apply to genetic nonresponder animals when the relevant linear polymer is coupled to an immunogenic carrier-protein such as MBSA.
Our recent studies have demonstrated the stimulation of specific suppressor T * BALB/c spleen cells (20 x 10 e) from normal mice or mice that had received 100/zg GT in Maaiox 3 days earlier were injected intravenously into normal BALB/c mice. $ Mice were immunized with i or 2 injections of GT-MBSA. Primary responses were elicited by injecting 10 ~g of GT as GT-MBSA, i.p. Mice were initially injected intraperitoneally with 50/zg of GT as GT-MBSA followed 3 days later by an i.p. injection of 10 ~g GT as GT-MBSA for secondary responses. 7 days al%er the 10 pg injection spleens were assayed for antigen-specific PFC. § ND, not determined. 
Summary
Primary responses to the linear polymers of L-glutamic acid, L-tyrosine, and Lalanine are restricted to the IgG class of antibodies. The appearance of specific IgM antibodies against these antigens is dependent upon secondary immunization, in contrast to many classical antigenic systems. The presence of an IgM response was verified by a direct plaque-forming cell assay, the inhibition of direct plaques by an antiserum specific for mouse /z-chain, and the physical separation of IgM and IgG GAT-specific antibodies by gel filtration. Preimmunization of the appropriate nonresponder strain with GAT or GT inhibits both the secondary IgM and IgG responses to GAT-MBSA and GT-MBSA, respectively. The tolerance observed is due to the induction of suppressor cells as demonstrated by cell transfer experiments.
